Cargando…
Maximizing Adherence and Gaining New Information For Your Chronic Obstructive Pulmonary Disease (MAGNIFY COPD): Study Protocol for the Pragmatic, Cluster Randomized Trial Evaluating the Impact of Dual Bronchodilator with Add-On Sensor and Electronic Monitoring on Clinical Outcomes
BACKGROUND: Poor treatment adherence in COPD patients is associated with poor clinical outcomes and increased healthcare burden. Personalized approaches for adherence management, supported with technology-based interventions, may offer benefits to patients and providers but are currently unproven in...
Autores principales: | Price, David, Jones, Rupert, Pfister, Pascal, Cao, Hui, Carter, Victoria, Kemppinen, Anu, Holzhauer, Björn, Kaplan, Alan, Clark, Allan, Halpin, David M G, Pinnock, Hilary, Chalmers, James D, van Boven, Job F M, Beeh, Kai M, Kostikas, Konstantinos, Roche, Nicolas, Usmani, Omar, Mastoridis, Paul |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Dove
2021
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8163732/ https://www.ncbi.nlm.nih.gov/pubmed/34079422 http://dx.doi.org/10.2147/POR.S302809 |
Ejemplares similares
-
COPD: maximization of bronchodilation
por: Nardini, Stefano, et al.
Publicado: (2014) -
The Role of Bronchodilators in Preventing Exacerbations of Chronic Obstructive Pulmonary Disease
por: Beeh, Kai M.
Publicado: (2016) -
Early bronchodilator action of glycopyrronium versus tiotropium in moderate-to-severe COPD patients: a cross-over blinded randomized study (Symptoms and Pulmonary function in the moRnING)
por: Marin, Jose M, et al.
Publicado: (2016) -
When is dual bronchodilation indicated in COPD?
por: Thomas, Mike, et al.
Publicado: (2017) -
Cost-effectiveness and budget impact of the fixed-dose dual bronchodilator combination tiotropium–olodaterol for patients with COPD in the Netherlands
por: van Boven, Job FM, et al.
Publicado: (2016)